Literature DB >> 2334876

National Cancer Institute sponsored cooperative clinical trials.

M A Friedman1, D F Cain.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2334876     DOI： 10.1002/1097-0142(19900515)65:10+<2376::aid-cncr2820651504>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  22 in total

1.  Participation of older patients with prostate cancer in Medicare eligible trials.

Authors:  Benjamin M Craig; Scott M Gilbert; Jill Boylston Herndon; Bruce Vogel; Gwendolyn P Quinn
Journal:  J Urol       Date:  2010-09       Impact factor: 7.450

2.  A Patient Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications: A Landscape of Haystacks and Needles.

Authors:  Eric B Lynam; Jiin Leaw; Matthew B Wiener
Journal:  Drug Inf J       Date:  2012-07

3.  Should criteria for inclusion in cancer clinical trials be expanded?

Authors:  David E Gerber; Sandi L Pruitt; Ethan A Halm
Journal:  J Comp Eff Res       Date:  2015-08       Impact factor: 1.744

4.  Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.

Authors:  Andrew L Laccetti; Sandi L Pruitt; Lei Xuan; Ethan A Halm; David E Gerber
Journal:  J Natl Cancer Inst       Date:  2015-02-09       Impact factor: 13.506

5.  Designing clinical protocols for optimal use: measuring attributes of treatment and cancer control trials.

Authors:  J E Veney; W P Kory; J M Barnsley; A D Kaluzny
Journal:  J Med Syst       Date:  1991-12       Impact factor: 4.460

6.  Conceptual Model for Accrual to Cancer Clinical Trials.

Authors:  Simon J Craddock Lee; Caitlin C Murphy; Ann M Geiger; David E Gerber; John V Cox; Rasmi Nair; Celette Sugg Skinner
Journal:  J Clin Oncol       Date:  2019-06-05       Impact factor: 44.544

7.  Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients?

Authors:  K Al-Baimani; H Jonker; T Zhang; G D Goss; S A Laurie; G Nicholas; P Wheatley-Price
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

8.  AccrualNet: Addressing Low Accrual Via a Knowledge-Based, Community of Practice Platform.

Authors:  Holly A Massett; Linda K Parreco; Rose Mary Padberg; Ellen S Richmond; Marie E Rienzo; Colleen E Ryan Leonard; Whitney Quesenbery; H William Killiam; Lenora E Johnson; David M Dilts
Journal:  J Oncol Pract       Date:  2011-10-21       Impact factor: 3.840

9.  Impact of prior cancer on eligibility for lung cancer clinical trials.

Authors:  David E Gerber; Andrew L Laccetti; Lei Xuan; Ethan A Halm; Sandi L Pruitt
Journal:  J Natl Cancer Inst       Date:  2014-09-24       Impact factor: 13.506

10.  Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.

Authors:  Sandra Garcia; Ajit Bisen; Jingsheng Yan; Xian-Jin Xie; Suresh Ramalingam; Joan H Schiller; David H Johnson; David E Gerber
Journal:  J Thorac Oncol       Date:  2017-08-09       Impact factor: 15.609
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.